Financials·Financial Exchanges & Data·$31.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.11 | N/A | +6.31% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.11 | N/A | +6.31% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on EPS growth, emphasizing their commitment to strategic initiatives. However, they did not provide specific revenue guidance.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance market offerings and customer engagement.
CBOE Global Markets reported a better-than-expected EPS, which contributed to a positive stock reaction, with shares rising 1.08%. The company did not disclose revenue figures, leaving some uncertainty. Management's focus on strategic initiatives suggests they are looking to drive future growth, but the lack of guidance may leave investors cautious.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIO-TECHNE CORP
Apr 30, 2019